MarketCap
Facebook
X
Telegram
Cardiovascular Systems Accounts Payables | CSII
Accounts payable — are the obligations of an organization to other legal entities or individuals that arise in cases when the company has acquired goods or services on deferred payment terms, has not paid taxes and fees, has wage arrears to employees, or has received loans and other liabilities. Accounts payable arise when an organization has already received some benefit but has not yet paid for it.Main types of accounts payable
| Type of liability | Example |
|---|---|
| To suppliers and contractors | Goods received but not yet paid for |
| Taxes and fees | VAT, income tax, etc., not paid on time |
| Salaries | Employee wages not paid |
| To budgets | Insurance contributions to funds not paid |
| To founders | Founders provided borrowed funds |
| To banks | Overdue loan payments |
| Other | Fines, penalties, forfeits, customer prepayments, etc. |
Impact on the company's financial performance
- Liquidity and solvency
Accounts payable are part of short-term liabilities, so they affect liquidity ratios - Financial stability
The higher the share of borrowed funds (including accounts payable), the lower the company's level of independence - Capital turnover
Moderate accounts payable can positively affect working capital by allowing the company to use “free” financing from suppliers (payment deferrals) - Risks and reputation
Large and especially overdue accounts payable may indicate financial difficulties. This can deter investors, partners, and lenders, and at a critical level of debt and lack of resources to repay it, bankruptcy proceedings may be initiated
Annual Accounts Payables Cardiovascular Systems
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14.4 M | 14.1 M | 11.5 M | 11.2 M | 10.4 M | 10.7 M | 8.51 M | 9.76 M | 9.7 M | 7.23 M | 5.61 M | 5.18 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 14.4 M | 5.18 M | 9.86 M |
Quarterly Accounts Payables Cardiovascular Systems
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 17.1 M | 16.8 M | 17.1 M | 13.6 M | 12.5 M | 12.9 M | 12.5 M | 12.9 M | 12.6 M | 14.1 M | 13.7 M | 13.4 M | 16.6 M | 13.1 M | 16.6 M | 12.4 M | 13 M | 13 M | 13 M | 9.84 M | 9.72 M | 10.7 M | 9.72 M | 8.81 M | 7.62 M | 8.76 M | 7.62 M | 8.34 M | 8.31 M | 9.82 M | 8.31 M | 17.5 M | 18.3 M | 18.2 M | 18.3 M | 11.3 M | 8.51 M | 8.52 M | 8.51 M | 6.18 M | 5.01 M | 5.6 M | 5.01 M | 5.07 M | 5.63 M | 5.2 M | 5.63 M | 5.2 M | 5.18 M | 5.18 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 18.3 M | 5.01 M | 10.8 M |
Accounts Payables of other stocks in the Medical devices industry
| Issuer | Accounts Payables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GBS
GBS
|
712 K | - | -0.57 % | $ 7.12 M |  USA |
 |
Second Sight Medical Products
EYES
|
1.03 M | - | -0.97 % | $ 54.4 M | USA |
 |
EDAP TMS S.A.
EDAP
|
12.6 M | - | - | $ 162 M |  France |
 |
Aziyo Biologics
AZYO
|
4.79 M | - | 1.37 % | $ 20.5 M | USA |
 |
Allied Healthcare Products
AHPI
|
1.21 M | - | 3.58 % | $ 2.21 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
26.9 M | $ 8.47 | 0.71 % | $ 618 M |  Israel |
 |
ClearPoint Neuro
CLPT
|
1.26 M | $ 13.96 | 0.67 % | $ 395 M | USA |
 |
Apollo Endosurgery
APEN
|
7.42 M | - | - | $ 475 M | USA |
 |
Avinger
AVGR
|
777 K | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
18.5 M | - | - | $ 3.31 B | USA |
 |
BIOLASE
BIOL
|
6.06 M | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
4.16 M | - | - | $ 16.4 M | USA |
 |
Dynatronics Corporation
DYNT
|
3.4 M | - | 14.99 % | $ 929 K | USA |
 |
Cutera
CUTR
|
19.8 M | - | -10.19 % | $ 1.99 M | USA |
 |
Eargo
EAR
|
6.5 M | - | - | $ 10.2 M | USA |
 |
Invacare Corporation
IVC
|
105 M | - | - | $ 24.7 M | USA |
 |
Inogen
INGN
|
20.3 M | $ 5.42 | 0.18 % | $ 144 M | USA |
 |
Integer Holdings Corporation
ITGR
|
113 M | $ 126.5 | 0.8 % | $ 4.39 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
18.8 M | $ 22.41 | 1.17 % | $ 526 M | USA |
 |
Cytosorbents Corporation
CTSO
|
2.87 M | $ 0.35 | 0.03 % | $ 21.8 M | USA |
 |
SmileDirectClub
SDC
|
30.5 M | - | -53.45 % | $ 9.71 M | USA |
 |
Sientra
SIEN
|
6.82 M | - | -16.59 % | $ 10.3 M | USA |
 |
Silk Road Medical, Inc
SILK
|
5.68 M | - | - | $ 1.07 B | USA |
 |
NanoVibronix
NAOV
|
719 K | - | - | $ 1.08 M | USA |
 |
Surgalign Holdings
SRGA
|
7.7 M | - | -32.98 % | $ 1.68 M | USA |
 |
ShockWave Medical
SWAV
|
8.87 M | - | - | $ 12.3 B | USA |
 |
NuVasive
NUVA
|
20.3 M | - | - | $ 2.07 B | USA |
 |
Natus Medical Incorporated
NTUS
|
36.4 M | - | 1.94 % | $ 1.05 B | USA |
 |
Nevro Corp.
NVRO
|
24.5 M | - | - | $ 217 M | USA |
|
LENSAR
LNSR
|
19 M | $ 8.58 | 4.0 % | $ 103 M | USA |
 |
ThermoGenesis Holdings
THMO
|
948 K | - | -25.84 % | $ 171 K | USA |
 |
Talis Biomedical Corporation
TLIS
|
1.34 M | - | 3.55 % | $ 7.96 M | USA |
 |
LivaNova PLC
LIVN
|
97.2 M | $ 81.92 | 0.89 % | $ 4.47 B |  Britain |
 |
Butterfly Network
BFLY
|
5.44 M | $ 7.36 | 0.96 % | $ 1.82 B | USA |
 |
Vapotherm
VAPO
|
5.05 M | - | 6.72 % | $ 34 M | USA |
 |
Acutus Medical
AFIB
|
1.28 M | - | -26.83 % | $ 2.62 M | USA |
 |
Globus Medical
GMED
|
98.9 M | $ 78.29 | 0.27 % | $ 10.6 B | USA |